SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001415684-17-000019
Filing Date
2017-05-01
Accepted
2017-05-01 14:05:34
Documents
9
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A mslp201610ka1.htm 10-K/A 355940
2 EXHIBIT 10.1 mslpex101.htm EX-10.1 691790
3 EXHIBIT 10.2 mslpex102.htm EX-10.2 102099
4 EXHIBIT 10.3 mslpex103.htm EX-10.3 55221
5 EXHIBIT 31.1 mslp2016kex311.htm EX-31.1 10915
6 EXHIBIT 31.2 mslp2016kex312.htm EX-31.2 11163
7 EXHIBIT 32.1 mslp2016kex321.htm EX-32.1 5219
8 EXHIBIT 32.2 mslp2016kex322.htm EX-32.2 5556
9 GRAPHIC g164971g103625g42y81.jpg GRAPHIC 26397
  Complete submission text file 0001415684-17-000019.txt   1275485
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-53166 | Film No.: 17799903
SIC: 2834 Pharmaceutical Preparations